Dr. William Chey’s research interests focus on the diagnosis and treatment of functional bowel disorders, acid-related disorders, and Helicobacter pylori infection.

Dr. Chey has received funding for his research from federal and private sources. He has been the principal investigator on numerous NIH grants, including "Esophageal sensation in patients with heartburn", "Differential cortical activation in response to visceral & somatic stimulation", "Non-gastrin secretagogue peptide in islet cell tumors", "Physiology and pathophysiology--secretin, cholecystokinin", and others.

Dr. Chey has also participated in and directed numerous national and international continuing medical education programs in gastroenterology.

Dr. Chey has authored more than 200 manuscripts and book chapters, and has served on the editorial boards of several subspecialty journals in Gastroenterology including Clinical Gastroenterology & Hepatology, Gastroenterology & Hepatology, and the World Journal of Gastroenterology. He is currently Co-editor in chief of American Journal of Gastroenterology.

Dr. Chey is member of the Board of Trustees of the American College of Gastroenterology, the Board of Directors of the Rome Foundation, and the Scientific Advisory Board of the International Foundation for Functional GI Disorders. He has served on various abstract review committees dealing with H pylori infection, gastroesophageal reflux disease, and functional bowel disease for Digestive Disease Week, and is past Chair of the Clinical Practice Section (2006-2008) of the American Gastroenterology Association. He is a member of the planning committee for the Rome IV meetings, during which criteria for the Functional Bowel Disorders will be updated and revised. He is also co-chair of the Rome Foundation Working Group addressing the role of food in Functional GI Disorders.

Dr. Chey has been elected to the roster of Best Doctors since 2001 and was named one of the top 75 gastroenterologists in the US by Beckers ASC in 2010.

Dr. Chey received his BA degree from the University of Pennsylvania followed by a medical degree and training in internal medicine at Emory University School of Medicine in Atlanta, GA. He went on to complete a fellowship in gastroenterology at the University of Michigan.

This Lectureship was established by Dr. Franklin Davidson in honor of Dr. Lawrence J, Brandt as "The Lawrence J. Brandt Lecture".

Objective

After attending this activity, participants will:

Understand the role of the gut microbiome in normal development and function of the GI tract

Review the data to support a role for the gut microbiome and immune activation in the pathogenesis of IBS

Review the efficacy of medical therapies targeting the gut microbiome and gut inflammation in IBS patients

Accreditation

Albert Einstein College of Medicine designates this educational activity for a maximum of 1 credit towards the AMA Physician’s Recognition Award. Each physician should claim only those credits that he/she actually spent in the educational activity.